These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 2893378

  • 1. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
    Kadar T, Redding TW, Ben-David M, Schally AV.
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):890-4. PubMed ID: 2893378
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV, Redding TW.
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [Abstract] [Full Text] [Related]

  • 3. Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma.
    Srkalovic G, Szende B, Redding TW, Groot K, Schally AV.
    Proc Soc Exp Biol Med; 1989 Dec; 192(3):209-18. PubMed ID: 2574866
    [Abstract] [Full Text] [Related]

  • 4. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia.
    Fekete M, Redding TW, Comaru-Schally AM, Pontes JE, Connelly RW, Srkalovic G, Schally AV.
    Prostate; 1989 Dec; 14(3):191-208. PubMed ID: 2471961
    [Abstract] [Full Text] [Related]

  • 5. Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.
    Fekete M, Zalatnai A, Schally AV.
    Cancer Lett; 1989 May; 45(2):87-91. PubMed ID: 2567204
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR, Radulovic S, Groot K, Schally AV.
    Prostate; 1992 May; 20(4):269-80. PubMed ID: 1376910
    [Abstract] [Full Text] [Related]

  • 7. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
    Fekete M, Wittliff JL, Schally AV.
    J Clin Lab Anal; 1989 May; 3(3):137-47. PubMed ID: 2569034
    [Abstract] [Full Text] [Related]

  • 8. Membrane receptors for peptides in experimental and human pancreatic cancers.
    Fekete M, Zalatnai A, Comaru-Schally AM, Schally AV.
    Pancreas; 1989 May; 4(5):521-8. PubMed ID: 2573055
    [Abstract] [Full Text] [Related]

  • 9. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
    Yano T, Pinski J, Szepeshazi K, Milovanovic SR, Groot K, Schally AV.
    Prostate; 1992 May; 20(4):297-310. PubMed ID: 1351672
    [Abstract] [Full Text] [Related]

  • 10. Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination.
    Szepeshazi K, Milovanovic S, Lapis K, Groot K, Schally AV.
    Breast Cancer Res Treat; 1992 May; 21(3):181-92. PubMed ID: 1355375
    [Abstract] [Full Text] [Related]

  • 11. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV.
    Endocrinology; 1990 Dec; 127(6):3052-60. PubMed ID: 2174343
    [Abstract] [Full Text] [Related]

  • 12. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.
    Srkalovic G, Wittliff JL, Schally AV.
    Cancer Res; 1990 Mar 15; 50(6):1841-6. PubMed ID: 2155060
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone.
    Torres-Aleman I, Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1985 Feb 15; 82(4):1252-6. PubMed ID: 2858096
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin.
    de Quijada MG, Redding TW, Coy DH, Torres-Aleman I, Schally AV.
    Proc Natl Acad Sci U S A; 1983 Jun 15; 80(11):3485-8. PubMed ID: 6134284
    [Abstract] [Full Text] [Related]

  • 15. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S, Comaru-Schally AM, Milovanovic S, Schally AV.
    Pancreas; 1993 Jan 15; 8(1):88-97. PubMed ID: 8093555
    [Abstract] [Full Text] [Related]

  • 16. Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH.
    Zalatnai A, Paz-Bouza JI, Redding TW, Schally AV.
    Prostate; 1988 Jan 15; 12(1):85-98. PubMed ID: 2894651
    [Abstract] [Full Text] [Related]

  • 17. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
    Redding TW, Schally AV, Radulovic S, Milovanovic S, Szepeshazi K, Isaacs JT.
    Cancer Res; 1992 May 01; 52(9):2538-44. PubMed ID: 1568223
    [Abstract] [Full Text] [Related]

  • 18. Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Pinski J, Halmos G, Szepeshazi K, Schally AV.
    Cancer; 1993 Dec 01; 72(11):3263-70. PubMed ID: 8242552
    [Abstract] [Full Text] [Related]

  • 19. Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.
    Paz-Bouza JI, Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1987 Feb 01; 84(4):1112-6. PubMed ID: 2881296
    [Abstract] [Full Text] [Related]

  • 20. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
    Schally AV, Kook AI, Monje E, Redding TW, Paz-Bouza JI.
    Proc Natl Acad Sci U S A; 1986 Nov 01; 83(22):8764-8. PubMed ID: 2946045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.